Trial Profile
A Phase 1 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Debio 1450 in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Afabicin (Primary) ; Afabicin (Primary) ; Afabicin (Primary) ; Pantoprazole
- Indications Staphylococcal infections
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Debiopharm
- 25 Apr 2017 Results presented at the 27th European Congress of Clinical Microbiology and Infectious Diseases
- 24 Feb 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov (for all 3 parts).
- 24 Feb 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov (for all 3 parts).